Department of Radiology and Neuroradiology, Klinikum Duisburg, Zu den Rehwiesen 9, 47055, Duisburg, Germany.
Neuroradiology. 2012 Jan;54(1):51-9. doi: 10.1007/s00234-011-0860-4. Epub 2011 Apr 1.
Vein of Galen aneurysmal malformation (VGAM) is a severe pediatric neurovascular disease. Children often present with congestive heart failure in the neonatal period. In the last decades, endovascular treatment became the first therapeutic option. The purpose of this study is to report our results in the treatment of VGAM with a combined transvenous and transarterial method in the last ten years.
In our cohort of 28 patients with VGAM, 22 patients were treated endovascularly between 1992 and 2010. In the last 10 years, a consecutive series of 14 children were treated with a combined transvenous and transarterial method. The therapeutic goal was immediate shunt reduction of the arteriovenous malformation, especially in the neonatal period. Closure of the fistulous connections was achieved by coiling using a combined transvenous and transarterial approach, called "kissing microcatheter technique".
Eight of 14 children presented in the neonatal period with severe congestive heart failure. The other six patients presented between the age of 2 and 17 months. One patient died due to a non-procedural complication in another hospital 2 years after the last treatment. Complete or >90% of angiographically confirmed closure of the malformation was documented in 11 of 14 patients. Normal or near-normal outcome was achieved in 9 of 13 surviving children, a non-favorable outcome was observed in four children. Control of heart failure was achieved in all patients.
Endovascular treatment of VGAM using a combined transvenous and transarterial method is a safe procedure with a low complication rate. The overall outcome can be improved, especially in the high-risk neonatal group with congestive heart failure.
静脉血管球瘤样畸形(VGAM)是一种严重的儿科神经血管疾病。患儿常在新生儿期出现充血性心力衰竭。在过去的几十年中,血管内治疗已成为首选治疗方法。本研究旨在报告过去十年中采用经静脉和经动脉联合方法治疗 VGAM 的结果。
在我们的 28 例 VGAM 患者中,1992 年至 2010 年间有 22 例接受了血管内治疗。在过去的 10 年中,连续有 14 例儿童采用经静脉和经动脉联合方法治疗。治疗目标是立即减少动静脉畸形的分流,尤其是在新生儿期。通过使用经静脉和经动脉联合的“亲吻微导管技术”进行线圈填塞来实现瘘管连接的闭合。
14 例患儿中有 8 例在新生儿期出现严重充血性心力衰竭,其余 6 例在 2 至 17 个月大时就诊。1 例患者在最后一次治疗后 2 年在另一家医院因非手术并发症死亡。14 例患者中有 11 例的畸形完全或>90%的血管造影证实闭合。在 13 例存活患儿中有 9 例获得了正常或接近正常的结局,4 例患儿的结局不理想。所有患者的心力衰竭均得到控制。
采用经静脉和经动脉联合方法的 VGAM 血管内治疗是一种安全的方法,并发症发生率低。特别是对于有充血性心力衰竭的高危新生儿组,可以改善整体预后。